Elena Tassi
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
- Immunology 10
- Immunotherapy and Immune Responses 6
- Co-authors
- Valerio Di Carlo (3 shared papers)Maria Pia Protti (5 shared papers)Marco Braga (3 shared papers)Claudio Doglioni (3 shared papers)Michele Reni (1 shared paper)Helios Recalde (1 shared paper)Ilenia Papa (1 shared paper)Lucia De Monte (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)Cell Death and Disease (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Elena Tassi
23 papers receiving 1.3k citations
Elena Tassi's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 547
- Oncology 646
- Cell Biology 218
- Immunology and Allergy 76
- Molecular Biology 554
Countries citing papers authored by Elena Tassi
This map shows the geographic impact of Elena Tassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Tassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Tassi more than expected).
Fields of papers citing papers by Elena Tassi
This network shows the impact of papers produced by Elena Tassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Tassi. The network helps show where Elena Tassi may publish in the future.
Co-authors
The 25 scholars most cited alongside Elena Tassi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer Hit paper breakdown → | 2011 | 530 |
| 2 | 1997 | 280 | |
| 3 | 2008 | 82 | |
| 4 | 2020 | 80 | |
| 5 | 2004 | 58 | |
| 6 | 2016 | 44 | |
| 7 | 2012 | 38 | |
| 8 | 2018 | 32 | |
| 9 | 2006 | 31 | |
| 10 | 2014 | 30 | |
| 11 | 2012 | 27 | |
| 12 | 2016 | 25 | |
| 13 | 2009 | 24 | |
| 14 | 2021 | 16 | |
| 15 | 2014 | 16 | |
| 16 | 2021 | 16 | |
| 17 | 2016 | 15 | |
| 18 | 2023 | 7 | |
| 19 | 2021 | 5 | |
| 20 | 2006 | 4 |
About Elena Tassi
Elena Tassi is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), Melanoma and MAPK Pathways (4 papers), Computational Drug Discovery Methods (2 papers), CRISPR and Genetic Engineering (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (547 citations), Oncology (646 citations), Cell Biology (218 citations), Immunology and Allergy (76 citations) and Molecular Biology (554 citations). Elena Tassi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Valerio Di Carlo, Maria Pia Protti, Marco Braga, Claudio Doglioni, Michele Reni, Helios Recalde, Ilenia Papa, Lucia De Monte, Elisa Santolini and Pier Paolo Di Fiore. Their work appears in journals such as Clinical Cancer Research, Frontiers in Immunology, Cancer Research, Cell Death and Disease and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.